Form 4: Medicine Man Technologies Director Acquires Shares and Grants Power of Attorney

Justin Dye, a director at Medicine Man Technologies, acquired 91,463 shares of common stock and granted a power of attorney for SEC filings.

Summary

• Justin Dye, a director and 10% owner of Medicine Man Technologies, acquired 91,463 shares of common stock on March 29, 2024, as compensation for board service.
• The shares were granted with an aggregate value of $75,000, based on the closing price of the common stock on the OTCQX Best Market on March 28, 2024.
• Following the transaction, Mr. Dye directly owns 1,830,979 shares.
• Mr. Dye also indirectly owns 9,287,500 shares through Dye Capital & Company and 500,000 shares through Dye Capital LLLP, but disclaims beneficial ownership except to the extent of his pecuniary interest.
• Additionally, Mr. Dye granted a power of attorney on April 2, 2024, to Philip McDermott, Christine Jones, and Zachary Weiss to handle SEC filings related to company securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing detailing an insider transaction. The director's share acquisition could be interpreted slightly positively, but it's not a major event.

Positives

• The acquisition of shares by a director could be seen as a positive signal, indicating confidence in the company's future.

Industry Context

This filing is a routine disclosure related to insider transactions and is common for publicly traded companies. It provides transparency into the actions of company insiders.

Stakeholder Impact

• The share acquisition by a director could have a minor positive impact on shareholder confidence.

Key Dates

Keywords

Medicine Man Technologies, Justin Dye, share acquisition, Form 4, power of attorney, beneficial ownership, director, SHWZ, SEC filings